[email protected]

国际临床研究杂志

International Journal of Clinical Research

您当前位置:首页 > 精选文章

International Journal of Clinical Research. 2024; 8: (9) ; 10.12208/j.ijcr.20240384 .

Comparison of efficacy of levamlodipine besylate tablet and nifedipine sustained-release tablet in the treatment of hypertension
苯磺酸左氨氯地平片与硝苯地平缓释片治疗高血压的效果比较

作者: 冀相廷 *

山东省聊城市阳谷县李台中心卫生院 山东聊城

*通讯作者: 冀相廷,单位:山东省聊城市阳谷县李台中心卫生院 山东聊城;

引用本文: 冀相廷 苯磺酸左氨氯地平片与硝苯地平缓释片治疗高血压的效果比较[J]. 国际临床研究杂志, 2024; 8: (9) : 176-178.
Published: 2024/9/28 15:14:18

摘要

目的 讨论及研究苯磺酸左氨氯地平片与硝苯地平缓释片治疗高血压的效果。方法 参与本次研究患者的数量为100例,时间范围2023年4月份至2024年4月份,对照组硝苯地平缓释片治疗,实验组患者提供苯磺酸左旋氨氯地平治疗,比较两组患者的治疗效果以及不良反应发生率,评估患者治疗前以及治疗八周后的血压水平。结果 两组患者在通过不同的治疗方式后,服用苯碘酸左旋氨氯地平治疗的实验组患者血压水平略优于对照组,但差异不大,p>0.05,从两组患者的治疗效果来看,两组患者的治疗效果差异不大,p>0.05,从两组患者的不良反应发生率来看,实验组患者的不良反应发生率更低,P<0.05。结论 为高血压患者提供苯磺酸左氨氯地平片治疗可以改善患者的血压水平,同时降低患者出现不良反应的机率,值得推广。

关键词: 苯磺酸左氨氯地平片;硝苯地片缓释片;高血压

Abstract

Objective: To discuss and study the effect of levamlodipine tablet and nifedipine sustained-release tablets in the treatment of hypertension.
Methods: the number of patients involved in the study is 100 cases, time range from April 2023 to April 2024, the control group nifedipine sustained-release treatment, experimental group patients with benzene amlodipine, compare the treatment effect and the incidence of adverse reactions, and evaluate the blood pressure level before and after eight weeks of treatment.
Results: After different treatment methods, the BP of levamlodipine was slightly better than the control group, but p> 0.05, the difference effect, p> 0.05, and the incidence of adverse reactions in both groups of patients, P <0.05.
Conclusion  : Providing levamlodipine tablets for hypertensive patients can improve the blood pressure level and reduce the probability of adverse effects.

Key words: Levamlodipine tablet; nifediate sustained-release tablet; hypertension

参考文献 References

[1] 刘文卓.苯磺酸左氨氯地平片与硝苯地平缓释片治疗高血压的效果比较[J].临床合理用药杂志,2024,17(10):46-49.

[2] 万丽文.苯磺酸左旋氨氯地平片治疗高血压临床治疗效果评价[J].中国科技期刊数据库 医药,2024(6):0019-0022.

[3] 孙晨捷,白鹏,屈改艳,杜晓艳.苯磺酸左氨氯地平片治疗高血压的临床疗效及对患者血压水平的影响[J].贵州医药,2024,48(1):53-54.

[4] 黄铮,刘小团.苯磺酸氨氯地平与硝苯地平缓释片治疗原发性高血压的临床疗效比较[J].临床合理用药杂志,2020,13(34):28-29.

[5] 刘思艺,许晓玲.比较苯磺酸氨氯地平片与硝苯地平控释片对原发性高血压清晨血压的影响[J].北方药学,2023, 20(9):35-37.

[6] Qian X ,Nan Y ,Shuang F , et al.Cost-effectiveness analysis of combining traditional Chinese medicine in the treatment of hypertension: compound Apocynum tablets combined with Nifedipine sustained-release tablets vs Nifedipine sustained-release tablets alone.[J].BMC complementary medicine and therapies,2020,20(1):330-330.

[7] 李建涛,郭树领.苯磺酸左氨氯地平片联合阿托伐他汀钙治疗高血压心脏病的临床疗效[J].深圳中西医结合杂志,2023,33(6):107-109.

[8] 祁承龙.酒石酸美托洛尔缓释片联合苯磺酸氨氯地平片治疗高血压合并慢性心力衰竭的临床效果[J].河南医学研究,2021,30(2):298-300.

[9] Zhaoqiang C ,Zhaohui Q ,Wenli C , et al.Efficacy and safety of olmesartan medoxomil-amlodipine besylate tablet in Chinese patients with essential hypertension: A prospective, single-arm, multi-center, real-world study.[J].Journal of clinical hypertension (Greenwich, Conn.),2023,26(1):5-16.

[10] Cui Z ,Qiu Z ,Cheng W , et al.Efficacy and safety of olmesartan medoxomil amlodipine besylate tablets (Sevikarsup®/sup) in older patients with essential hypertension: Subgroup analysis from the Sevikar study.[J].Experimental and therapeutic medicine,2024, 27(2):51-51.